Statistical Insights
The aim of drug development is to get an effective and safe drug to market to help patients. However, the definition of a successful drug development “program” is dependent on more than just regulatory success.
What is needed to move the dial on the use of innovative trial designs?
How building models opened up new possibilities.
Why more data does not always mean useful data.
How novel approaches to clinical trial design and analysis supports delivery of treatments for rare diseases.
Learnings from the COVID-19 Pandemic.
How synthetic control arms can add another dimension to clinical trials.
How a better understanding of mutual relationships improves clinical trial design.
Effective visualisations are a vital way to relay information related to clinical development and decision-making in the healthcare setting.
The first in-person PSI Conference since the start of the COVID-19 pandemic was held last month at the Gothia Towers in Gothenburg, Sweden.
Clinical development is extremely costly, in terms of money, time and patient burden.
In clinical development, clear, precise and transparent specification of the research question and associated treatment effects of interest are vital.
Recently, I attended the IoT Clinical Trials Europe conference on integrating IoT (the internet of things) and emerging technologies to optimise clinical trials and patient outcomes.
When I first started working in the pharmaceutical industry, most clinical trials used paper case report forms (CRF) to collect information from patients.
Simulation is an invaluable tool for evaluating and mitigating the risks of clinical trials before conducting the studies in real time
With recruitment often a key barrier to study success, discover how smarter trial design using study simulation can help to relieve this
How the pandemic has heightened interest in unlocking the value of RWD.
Why aren’t biostatisticians involved earlier in the clinical trial design process?
How synthetic data offers a solution to unleashing powerful insights from real-world data.
How unlocking data insights from the real world will help us to see the bigger picture.
Why Belfast is a great place to set up a life science business.
In the wake of a tumultuous 2020, I have taken the opportunity to reflect on the progress Exploristics has made as a company and reappraise my reasons for setting it up.
The challenges faced by the Pharmaceutical Industry have been well documented…
The COVID-19 pandemic has demonstrated the importance of science and the dedication of scientists in overcoming the challenges that we face…
Statistical Insights
The aim of drug development is to get an effective and safe drug to market to help patients. However, the definition of a successful drug development “program” is dependent on more than just regulatory success.
What is needed to move the dial on the use of innovative trial designs?
How building models opened up new possibilities.
Why more data does not always mean useful data.
How novel approaches to clinical trial design and analysis supports delivery of treatments for rare diseases.
Learnings from the COVID-19 Pandemic.
How synthetic control arms can add another dimension to clinical trials.
How a better understanding of mutual relationships improves clinical trial design.
Effective visualisations are a vital way to relay information related to clinical development and decision-making in the healthcare setting.
The first in-person PSI Conference since the start of the COVID-19 pandemic was held last month at the Gothia Towers in Gothenburg, Sweden.
Clinical development is extremely costly, in terms of money, time and patient burden.
In clinical development, clear, precise and transparent specification of the research question and associated treatment effects of interest are vital.
Recently, I attended the IoT Clinical Trials Europe conference on integrating IoT (the internet of things) and emerging technologies to optimise clinical trials and patient outcomes.
When I first started working in the pharmaceutical industry, most clinical trials used paper case report forms (CRF) to collect information from patients.
Simulation is an invaluable tool for evaluating and mitigating the risks of clinical trials before conducting the studies in real time
With recruitment often a key barrier to study success, discover how smarter trial design using study simulation can help to relieve this
How the pandemic has heightened interest in unlocking the value of RWD.
Why aren’t biostatisticians involved earlier in the clinical trial design process?
How synthetic data offers a solution to unleashing powerful insights from real-world data.
How unlocking data insights from the real world will help us to see the bigger picture.
Why Belfast is a great place to set up a life science business.
In the wake of a tumultuous 2020, I have taken the opportunity to reflect on the progress Exploristics has made as a company and reappraise my reasons for setting it up.
The challenges faced by the Pharmaceutical Industry have been well documented…
The COVID-19 pandemic has demonstrated the importance of science and the dedication of scientists in overcoming the challenges that we face…
Statistical Insights
The aim of drug development is to get an effective and safe drug to market to help patients. However, the definition of a successful drug development “program” is dependent on more than just regulatory success.
What is needed to move the dial on the use of innovative trial designs?
How building models opened up new possibilities.
Why more data does not always mean useful data.
How novel approaches to clinical trial design and analysis supports delivery of treatments for rare diseases.
Learnings from the COVID-19 Pandemic.
How synthetic control arms can add another dimension to clinical trials.
How a better understanding of mutual relationships improves clinical trial design.
Effective visualisations are a vital way to relay information related to clinical development and decision-making in the healthcare setting.
The first in-person PSI Conference since the start of the COVID-19 pandemic was held last month at the Gothia Towers in Gothenburg, Sweden.
Clinical development is extremely costly, in terms of money, time and patient burden.
In clinical development, clear, precise and transparent specification of the research question and associated treatment effects of interest are vital.
Recently, I attended the IoT Clinical Trials Europe conference on integrating IoT (the internet of things) and emerging technologies to optimise clinical trials and patient outcomes.
When I first started working in the pharmaceutical industry, most clinical trials used paper case report forms (CRF) to collect information from patients.
Simulation is an invaluable tool for evaluating and mitigating the risks of clinical trials before conducting the studies in real time
With recruitment often a key barrier to study success, discover how smarter trial design using study simulation can help to relieve this
How the pandemic has heightened interest in unlocking the value of RWD.
Why aren’t biostatisticians involved earlier in the clinical trial design process?
How synthetic data offers a solution to unleashing powerful insights from real-world data.
How unlocking data insights from the real world will help us to see the bigger picture.
Why Belfast is a great place to set up a life science business.
In the wake of a tumultuous 2020, I have taken the opportunity to reflect on the progress Exploristics has made as a company and reappraise my reasons for setting it up.
The challenges faced by the Pharmaceutical Industry have been well documented…
The COVID-19 pandemic has demonstrated the importance of science and the dedication of scientists in overcoming the challenges that we face…
Statistical Insights
The aim of drug development is to get an effective and safe drug to market to help patients. However, the definition of a successful drug development “program” is dependent on more than just regulatory success.
What is needed to move the dial on the use of innovative trial designs?
How building models opened up new possibilities.
Why more data does not always mean useful data.
How novel approaches to clinical trial design and analysis supports delivery of treatments for rare diseases.
Learnings from the COVID-19 Pandemic.
How synthetic control arms can add another dimension to clinical trials.
How a better understanding of mutual relationships improves clinical trial design.
Effective visualisations are a vital way to relay information related to clinical development and decision-making in the healthcare setting.
The first in-person PSI Conference since the start of the COVID-19 pandemic was held last month at the Gothia Towers in Gothenburg, Sweden.
Clinical development is extremely costly, in terms of money, time and patient burden.
In clinical development, clear, precise and transparent specification of the research question and associated treatment effects of interest are vital.
Recently, I attended the IoT Clinical Trials Europe conference on integrating IoT (the internet of things) and emerging technologies to optimise clinical trials and patient outcomes.
When I first started working in the pharmaceutical industry, most clinical trials used paper case report forms (CRF) to collect information from patients.
Simulation is an invaluable tool for evaluating and mitigating the risks of clinical trials before conducting the studies in real time
With recruitment often a key barrier to study success, discover how smarter trial design using study simulation can help to relieve this
How the pandemic has heightened interest in unlocking the value of RWD.
Why aren’t biostatisticians involved earlier in the clinical trial design process?
How synthetic data offers a solution to unleashing powerful insights from real-world data.
How unlocking data insights from the real world will help us to see the bigger picture.
Why Belfast is a great place to set up a life science business.
In the wake of a tumultuous 2020, I have taken the opportunity to reflect on the progress Exploristics has made as a company and reappraise my reasons for setting it up.
The challenges faced by the Pharmaceutical Industry have been well documented…
The COVID-19 pandemic has demonstrated the importance of science and the dedication of scientists in overcoming the challenges that we face…
Want to find out more? Get in touch.